Drugs / Lactobacillus rhamnosus GG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01790035 | Aug 2014 → Jan 2017 | digestive system neoplasm | Washington University School of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus rhamnosus GG | “Lactobacillus rhamnosus GG (LGG), a probiotic, given by gavage is radioprotective of the mouse intestine.” PMID 29934438 ↗ Jun 2018 |
| Known as | LGG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01790035 ↗ |
| Modality | Other / unclassified | “Lactobacillus rhamnosus GG (LGG), a probiotic” PMID 29934438 ↗ Jun 2018 |
| Route | Oral | “LGG (containing 10\^10 viable bacteria) taken by mouth twice daily” NCT01790035 ↗ |